loadpatents
name:-0.0051898956298828
name:-0.013540983200073
name:-0.00047397613525391
Pfahl; Magnus Patent Filings

Pfahl; Magnus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pfahl; Magnus.The latest application filed is for "heterocyclic amide derivatives for the treatment of diabetes and other diseases".

Company Profile
0.16.16
  • Pfahl; Magnus - Solana Beach CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted heterocycles for the treatment of diabetes and other diseases
Grant 7,226,940 - Pfahl , et al. June 5, 2
2007-06-05
Bicyclic heterocycles for the treatment of diabetes and other diseases
Grant 7,196,108 - Pfahl , et al. March 27, 2
2007-03-27
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
Grant 7,153,875 - Pfahl , et al. December 26, 2
2006-12-26
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
App 20060241138 - Pfahl; Magnus ;   et al.
2006-10-26
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
Grant 7,102,000 - Pfahl , et al. September 5, 2
2006-09-05
Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors
Grant 7,098,310 - Pfahl , et al. August 29, 2
2006-08-29
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
App 20060160796 - Pfahl; Magnus ;   et al.
2006-07-20
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
Grant 7,071,218 - Pfahl , et al. July 4, 2
2006-07-04
Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors
Grant 7,026,125 - Pfahl , et al. April 11, 2
2006-04-11
Substituted heterocycles for the treatment of diabetes and other diseases
App 20060004059 - Pfahl; Magnus ;   et al.
2006-01-05
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
Grant 6,974,826 - Pfahl , et al. December 13, 2
2005-12-13
RXR activating molecules
App 20050209286 - Pfahl, Magnus ;   et al.
2005-09-22
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
App 20050070581 - Pfahl, Magnus ;   et al.
2005-03-31
Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
App 20050038098 - Tachdjian, Catherine ;   et al.
2005-02-17
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
App 20050014767 - Pfahl, Magnus ;   et al.
2005-01-20
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
Grant 6,825,226 - Pfahl , et al. November 30, 2
2004-11-30
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
Grant 6,765,013 - Pfahl , et al. July 20, 2
2004-07-20
2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
App 20040097566 - Pfahl, Magnus ;   et al.
2004-05-20
Bicyclic heterocycles for the treatment of diabetes and other diseases
App 20040034004 - Pfahl, Magnus ;   et al.
2004-02-19
Method of inhibiting transcription utilizing nuclear receptors
Grant 6,683,047 - Pfahl , et al. January 27, 2
2004-01-27
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
App 20030216432 - Pfahl, Magnus ;   et al.
2003-11-20
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
App 20030153606 - Pfahl, Magnus ;   et al.
2003-08-14
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
App 20030144329 - Pfahl, Magnus ;   et al.
2003-07-31
RXR activating molecules
App 20030105333 - Pfahl, Magnus ;   et al.
2003-06-05
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
App 20030083357 - Pfahl, Magnus ;   et al.
2003-05-01
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
App 20030073745 - Pfahl, Magnus ;   et al.
2003-04-17
Heterocyclic derivatives for the treatment of diabetes and other diseases
Grant 6,515,003 - Pfahl , et al. February 4, 2
2003-02-04
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
Grant 6,462,064 - Pfahl , et al. October 8, 2
2002-10-08
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
App 20020143182 - Pfahl, Magnus ;   et al.
2002-10-03
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
Grant 6,127,415 - Pfahl , et al. October 3, 2
2000-10-03
RXR homodimer formation
Grant 5,824,484 - Pfahl , et al. October 20, 1
1998-10-20
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
Grant 5,466,861 - Dawson , et al. November 14, 1
1995-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed